Back to Agenda
How Can Real-World Evidence be Communicated Compliantly to Payers or Healthcare Providers?
Session Chair(s)
Ruslan Horblyuk, PHD, MA
Chief Strategic Consulting Officer, AESARA, United States
This session will discuss the discourse on how real-world data could produce real-world evidence promotional communications to inform important treatment and access decisions and would meet the evidence standards of these two available FDA Guidances.
Learning Objective : Describe how real-world evidence should be designed, analyzed, and communicated compliantly to payers or healthcare providers; Discuss ways in which real-world data and real-world evidence could meet the evidence standard for compliant communications.
Speaker(s)
Stephen Shinall, PHD
Director of Regulatory Affairs, Biogen, United States
Industry Perspective
Danny Yeh, PHD
Senior Director, Health Policy and Systems Research, US Medical Affairs, Genentech, A Member of the Roche Group, United States
Industry Perspective
Alicia Mack, PHARMD
Founder | and AESARA Consulting Partner , Aleysheya, LLC | and AESARA, United States
Industry Perspective
Have an account?